Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Borgeson Blake sold 40,000 Recursion Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 3, 2026 · Filed Nov 4, 2026
On Nov 3, 2026, Borgeson Blake (Director) sold 40,000 Recursion Pharmaceuticals, Inc. shares at US$3.88 for US$155K under a trading plan, leaving 6,068,287 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 40,000 shares
- Price
- US$3.88
- Value
- US$155K
- Holding after
- 6,068,287 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | Class A Common Stock | Sale | 40,000 | US$3.88 | 6,068,287 | Direct |
Source
Download original · View original at SEC
Related
- Recursion Pharmaceuticals, Inc.
- Borgeson Blake
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Borgeson Blake · Sep 2, 2026
- Form 4 · Borgeson Blake · Aug 6, 2026
- Form 4 · Borgeson Blake · Jul 9, 2026
- Form 4 · Borgeson Blake · Jun 22, 2026
- Form 4 · Taylor Ben R · Nov 18, 2026
- Form 4 · Hallett David · Nov 18, 2026
- Form 4 · Khan Najat · Nov 18, 2026
- Schedule 13G/A · ARK Investment Management LLC · Nov 13, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026